Sanofi and partner seek European Medicines Agency review for sleep sickness product
PARIS (Reuters) - French healthcare group Sanofi, along with its business partner, has asked the European Medicines Agency (EMA) to review the fexinidazole product for the treatment of sleeping sickness, the company said on Wednesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: European Medicines Agency (EMA) | France Health | Health | Sleep Disorders | Sleep Medicine | Sleeping Sickness